*Refresh the page if the below document does not appear.
India leads as global pharma confidence hikes in Annual CPHI Pharma Index
Pharma confidence in growth, innovation, and manufacturing quality have hit a record high in the CPHI annual survey held in Frankfurt (World’s largest pharma event) from November 1st-3rd.
Viatris buys Taparias' eyecare for ₹2,460 Crore
Viatris Inc. has decided to acquire “Famy Life Sciences” Taparias’ eyecare (Opthalmology) business for around $300 Million. In a statement, the company said that the Taparia family that owned “Famy Care Group” will continue to grow their non-ophthalmic business.
JB Pharma launches RANRAFT to strengthen its position in Gastroenterology market
JB Pharma, makers of the blockbuster drug Rantac announced the launch of a new unique formulation named RANRAFT to provide quick relief to heartburn and acid reflux by neutralizing excess acid in the stomach and preventing acid reflux.
Zydus receives EIR from US FDA for Moraiya facility
Zydus Lifesciences declared that the US regulatory authority issued an EIR (Establishment Inspection Report) and closed the inspection of the Moraiya, Ahmedabad manufacturing unit with Voluntary Action Needed.
Novartis expands European antibiotics investment budget by 50 Million Euros
Sandoz, a Generic drugmaker belonging to the parent company Novartis, decided to increase its European antibiotics production network by 50 million Euros due to a rise in the demand for antibiotics globally. The total budget now has become 250 million Euros.
IOL Chemicals and Pharma to market heartburn drug API in European market
IOL Chemicals and Pharmaceuticals Limited (IOL) announced that they have received EDQM certification to supply Pantoprazole Sodium Sesquihydrate API (Active Pharmaceutical Ingredient) across the European market.